Alzheimer’s Drug Targets People With Mild Cognitive Impairment. What Does That Mean?
(By Judith Graham for Kaiser Health News) The approval of a controversial new drug for Alzheimer’s disease, Aduhelm, is shining
Read More
FDA
The FDA OKs Pfizer-BioNTech Booster For People 65+ Or At High Risk For Severe COVID
(By Scott Hensley for NPR) The Food and Drug Administration authorized a booster dose Wednesday of the Pfizer-BioNTech COVID-19 vaccine
Read MoreFDA vaccine regulators argue against Covid-19 vaccine boosters in new international review
(By Andrew Joseph for STAT) A group of international experts — including, notably, two outgoing Food and Drug Administration vaccine
Read MoreWhy At-Home Rapid Covid Tests Cost So Much, Even After Biden’s Push for Lower Prices
(By Hannah Norman for Kaiser Health News) Rapid at-home covid tests are flying off store shelves across the nation and
Read MoreCongress demands documents from FDA on controversial approval of Biogen’s Alzheimer’s drug
(By Rachel Cohrs for STAT) WASHINGTON — Lawmakers have requested data and documents from the Food and Drug Administration related
Read MoreApple, Bose and Others Pump Up the Volume on Hearing Aid Options, Filling Void Left by FDA
(By Phil Galewitz for Kaiser Health News) Spurred by decades of complaints about the high cost of hearing aids, Congress
Read MoreFDA grants full approval to Covid-19 vaccine developed by Pfizer, BioNTech
(By Helen Branswell and Andrew Joseph for STAT) The Food and Drug Administration on Monday granted full approval to the
Read More‘We Sent a Terrible Message’: Scientists Say Biden Jumped the Gun With Vaccine Booster Plan
(By Rachana Pradhan for Kaiser Health News) The Biden administration’s plans to make covid-19 booster shots available next month has
Read MoreReserve purple wristbands to identify DNR status, FDA tells device makers
(By Erica Carbajal for Becker’s Hospital Review) The FDA is asking medical device manufacturers to avoid giving purple wristbands to
Read MoreRush to Boosters Sparks Confusion, Differing Recommendations
(By Sarah Jane Tribble for Kaiser Health News) When the Food and Drug Administration announced last week that a third
Read More